• Je něco špatně v tomto záznamu ?

Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer

G. Piccinno, KN. Thompson, P. Manghi, AR. Ghazi, AM. Thomas, A. Blanco-Míguez, F. Asnicar, K. Mladenovic, F. Pinto, F. Armanini, M. Punčochář, E. Piperni, V. Heidrich, G. Fackelmann, G. Ferrero, S. Tarallo, LH. Nguyen, Y. Yan, NA. Keles, BG....

. 2025 ; 31 (7) : 2416-2429. [pub] 20250603

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25022532

Grantová podpora
CGCATF-2023/100041 Cancer Research UK (CRUK)
U01 CA176726 NCI NIH HHS - United States
OT2 CA297205 NCI NIH HHS - United States
825410 EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
1OT2CA297205-01 U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics)
R35 CA253185 NCI NIH HHS - United States
U01 CA230551 NCI NIH HHS - United States
101045015 EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
OT2 CA297680 NCI NIH HHS - United States
U01 CA261961 NCI NIH HHS - United States
R01 CA263776 NCI NIH HHS - United States
CGCATF-2023/100036 Cancer Research UK (CRUK)
OT2CA297680 U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics)

Associations between the gut microbiome and colorectal cancer (CRC) have been uncovered, but larger and more diverse studies are needed to assess their potential clinical use. We expanded upon 12 metagenomic datasets of patients with CRC (n = 930), adenomas (n = 210) and healthy control individuals (n = 976; total n = 2,116) with 6 new cohorts (n = 1,625) providing granular information on cancer stage and the anatomic location of tumors. We improved CRC prediction accuracy based solely on gut metagenomics (average area under the curve = 0.85) and highlighted the contribution of 19 newly profiled species and distinct Fusobacterium nucleatum clades. Specific gut species distinguish left-sided versus right-sided CRC (area under the curve = 0.66) with an enrichment of oral-typical microbes. We identified strain-specific CRC signatures with the commensal Ruminococcus bicirculans and Faecalibacterium prausnitzii showing subclades associated with late-stage CRC. Our analysis confirms that the microbiome can be a clinical target for CRC screening and characterizes it as a biomarker for CRC progression.

Biomedical Center Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Candiolo Cancer Institute FPO IRCCS Candiolo Italy

Center of Clinical Investigations for In Situ Biotherapies of Cancer INSERM CIC1428 Villejuif France

Clinical and Translational Epidemiology Unit Massachusetts General Hospital Boston MA USA

Department CIBIO University of Trento Trento Italy

Department of Biophysics School of Medicine Yeditepe University Istanbul Turkey

Department of Biostatistics Harvard T H Chan School of Public Health Boston MA USA

Department of Clinical and Biological Sciences University of Torino Torino Italy

Department of Colorectal Surgery Clinica S Rita Vercelli Italy

Department of Computer Science University of Torino Torino Italy

Department of Hepatogastroenterology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Medical Biology School of Medicine Yeditepe University Istanbul Turkey

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic

Department of Surgery University Hospital and Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy

Departments of Epidemiology and Nutrition Harvard T H Chan School of Public Health Boston MA USA

Faculté de Médecine Université Paris Saclay Kremlin Bicêtre France

Graduate School of Natural and Applied Sciences Yeditepe University Istanbul Turkey

Gustave Roussy Villejuif France

Harvard Chan Microbiome in Public Health Center Harvard T H Chan School of Public Health Boston MA USA

IEO European Institute of Oncology IRCCS Milan Italy

Infectious Disease and Microbiome Program Broad Institute of MIT and Harvard Cambridge MA USA

Institut National de la Santé Et de la Recherche Médicale U1015 Equipe Labellisée Ligue Nationale contre le Cancer Villejuif France

Institute of Biology and Medical Genetics 1st Medical Faculty Charles University Prague Czech Republic

Italian Institute for Genomic Medicine c o IRCCS Candiolo Candiolo Italy

Masaryk Memorial Cancer Institute Brno Czech Republic

RECETOX Faculty of Science Masaryk University Brno Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25022532
003      
CZ-PrNML
005      
20251023080356.0
007      
ta
008      
251014s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41591-025-03693-9 $2 doi
035    __
$a (PubMed)40461820
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Piccinno, Gianmarco $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000319471817
245    10
$a Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer / $c G. Piccinno, KN. Thompson, P. Manghi, AR. Ghazi, AM. Thomas, A. Blanco-Míguez, F. Asnicar, K. Mladenovic, F. Pinto, F. Armanini, M. Punčochář, E. Piperni, V. Heidrich, G. Fackelmann, G. Ferrero, S. Tarallo, LH. Nguyen, Y. Yan, NA. Keles, BG. Tuna, V. Vymetalkova, M. Trompetto, V. Liska, T. Hucl, P. Vodicka, B. Bencsiková, M. Čarnogurská, V. Popovici, F. Marmorino, C. Cremolini, B. Pardini, F. Cordero, M. Song, AT. Chan, L. Derosa, L. Zitvogel, C. Huttenhower, A. Naccarati, E. Budinska, N. Segata
520    9_
$a Associations between the gut microbiome and colorectal cancer (CRC) have been uncovered, but larger and more diverse studies are needed to assess their potential clinical use. We expanded upon 12 metagenomic datasets of patients with CRC (n = 930), adenomas (n = 210) and healthy control individuals (n = 976; total n = 2,116) with 6 new cohorts (n = 1,625) providing granular information on cancer stage and the anatomic location of tumors. We improved CRC prediction accuracy based solely on gut metagenomics (average area under the curve = 0.85) and highlighted the contribution of 19 newly profiled species and distinct Fusobacterium nucleatum clades. Specific gut species distinguish left-sided versus right-sided CRC (area under the curve = 0.66) with an enrichment of oral-typical microbes. We identified strain-specific CRC signatures with the commensal Ruminococcus bicirculans and Faecalibacterium prausnitzii showing subclades associated with late-stage CRC. Our analysis confirms that the microbiome can be a clinical target for CRC screening and characterizes it as a biomarker for CRC progression.
650    _2
$a lidé $7 D006801
650    12
$a kolorektální nádory $x mikrobiologie $x patologie $x genetika $x diagnóza $7 D015179
650    12
$a feces $x mikrobiologie $7 D005243
650    12
$a metagenom $x genetika $7 D054892
650    12
$a střevní mikroflóra $x genetika $7 D000069196
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a metagenomika $x metody $7 D056186
650    _2
$a Fusobacterium nucleatum $x genetika $7 D016967
650    _2
$a lidé středního věku $7 D008875
650    _2
$a kohortové studie $7 D015331
650    _2
$a senioři $7 D000368
650    _2
$a adenom $x mikrobiologie $x patologie $x genetika $7 D000236
650    _2
$a Ruminococcus $x genetika $7 D045857
650    _2
$a Faecalibacterium prausnitzii $x genetika $7 D000070037
655    _2
$a časopisecké články $7 D016428
700    1_
$a Thompson, Kelsey N $u Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA $1 https://orcid.org/0000000290749116
700    1_
$a Manghi, Paolo $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000308466529
700    1_
$a Ghazi, Andrew R $u Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
700    1_
$a Thomas, Andrew Maltez $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000157893354
700    1_
$a Blanco-Míguez, Aitor $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000173865572
700    1_
$a Asnicar, Francesco $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000337321468
700    1_
$a Mladenovic, Katarina $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0009000261810296
700    1_
$a Pinto, Federica $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000245394811
700    1_
$a Armanini, Federica $u Department CIBIO, University of Trento, Trento, Italy
700    1_
$a Punčochář, Michal $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000219159391
700    1_
$a Piperni, Elisa $u Department CIBIO, University of Trento, Trento, Italy $u IEO, European Institute of Oncology, IRCCS, Milan, Italy $1 https://orcid.org/0000000193617875
700    1_
$a Heidrich, Vitor $u Department CIBIO, University of Trento, Trento, Italy $1 https://orcid.org/0000000166179187
700    1_
$a Fackelmann, Gloria $u Department CIBIO, University of Trento, Trento, Italy
700    1_
$a Ferrero, Giulio $u Department of Clinical and Biological Sciences, University of Torino, Torino, Italy $u Department of Computer Science, University of Torino, Torino, Italy $1 https://orcid.org/0000000245800680
700    1_
$a Tarallo, Sonia $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Italy $u Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
700    1_
$a Nguyen, Long H $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA $1 https://orcid.org/0000000254364219
700    1_
$a Yan, Yan $u Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA
700    1_
$a Keles, Nazim A $u Department of Medical Biology, School of Medicine, Yeditepe University, Istanbul, Turkey $u Graduate School of Natural and Applied Sciences, Yeditepe University, Istanbul, Turkey
700    1_
$a Tuna, Bilge G $u Department of Biophysics, School of Medicine, Yeditepe University, Istanbul, Turkey
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic
700    1_
$a Trompetto, Mario $u Department of Colorectal Surgery, Clinica S. Rita, Vercelli, Italy
700    1_
$a Liska, Vaclav $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic $u Department of Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic
700    1_
$a Hucl, Tomas $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vodicka, Pavel $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic
700    1_
$a Bencsiková, Beatrix $u Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Čarnogurská, Martina $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Popovici, Vlad $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Marmorino, Federica $u Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
700    1_
$a Cremolini, Chiara $u Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
700    1_
$a Pardini, Barbara $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Italy $u Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy $1 https://orcid.org/0000000195714257
700    1_
$a Cordero, Francesca $u Department of Computer Science, University of Torino, Torino, Italy $1 https://orcid.org/0000000231433330
700    1_
$a Song, Mingyang $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA $u Departments of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
700    1_
$a Chan, Andrew T $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA $1 https://orcid.org/0000000172846767
700    1_
$a Derosa, Lisa $u Gustave Roussy, Villejuif, France $u Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France $u Center of Clinical Investigations for In Situ Biotherapies of Cancer (BIOTHERIS), INSERM CIC1428, Villejuif, France
700    1_
$a Zitvogel, Laurence $u Gustave Roussy, Villejuif, France $u Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France $u Center of Clinical Investigations for In Situ Biotherapies of Cancer (BIOTHERIS), INSERM CIC1428, Villejuif, France $u Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France $1 https://orcid.org/0000000315960998 $7 mub20201063380
700    1_
$a Huttenhower, Curtis $u Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA $u Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA $1 https://orcid.org/0000000211100096
700    1_
$a Naccarati, Alessio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Italy $u Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy $1 https://orcid.org/0000000157740905 $7 xx0118173
700    1_
$a Budinska, Eva $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Segata, Nicola $u Department CIBIO, University of Trento, Trento, Italy. nicola.segata@unitn.it $u IEO, European Institute of Oncology, IRCCS, Milan, Italy. nicola.segata@unitn.it $1 https://orcid.org/0000000215835794
773    0_
$w MED00003459 $t Nature medicine $x 1546-170X $g Roč. 31, č. 7 (2025), s. 2416-2429
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40461820 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023080402 $b ABA008
999    __
$a ok $b bmc $g 2417345 $s 1260695
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 31 $c 7 $d 2416-2429 $e 20250603 $i 1546-170X $m Nature medicine $n Nat Med $x MED00003459
GRA    __
$a CGCATF-2023/100041 $p Cancer Research UK (CRUK)
GRA    __
$a U01 CA176726 $p NCI NIH HHS $2 United States
GRA    __
$a OT2 CA297205 $p NCI NIH HHS $2 United States
GRA    __
$a 825410 $p EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
GRA    __
$a 1OT2CA297205-01 $p U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics)
GRA    __
$a R35 CA253185 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA230551 $p NCI NIH HHS $2 United States
GRA    __
$a 101045015 $p EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
GRA    __
$a OT2 CA297680 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA261961 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA263776 $p NCI NIH HHS $2 United States
GRA    __
$a CGCATF-2023/100036 $p Cancer Research UK (CRUK)
GRA    __
$a OT2CA297680 $p U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics)
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace